Vaccinex voluntarily delists from Nasdaq; Form 25 filing expected March 17, 2025

VACCINEX, INC.

Nasdaq trading suspended since December 18, 2024 following a hearing panel determination to delist.
Company notified Nasdaq on March 7, 2025 of its intention to delist; filing Form 25 on or about March 17.
Stock will continue to trade on OTC Pink under symbol VCNX.
Vaccinex plans to continue development of pepinemab in Alzheimer's and cancer via partnerships and grants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.